Get started
Author

Christopher Condin

ORCID: 0009-0009-6265-3094
Observed ORCID: 0009-0009-6265-3094
OpenAlex ID: A5079309632
Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial
2023 · Ron Wald, Stephane Gaudry, et al. · Intensive Care Medicine · 76
PDF
Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial
2022 · Sean M. Bagshaw, Ary Serpa Neto, et al. · Intensive Care Medicine · 30
A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial
2022 · Fernando G. Zampieri, Bruno R. da Costa, et al. · Critical Care · 20
PDF
Factors associated with adverse haemodynamic events during the STARRT-AKI trial: a post-hoc secondary analysis
2025 · Yvelynne P. Kelly, Bruno R. da Costa, et al. · Critical Care · 5
PDF
Cost-Utility Analysis of Accelerated and Standard Strategies for Renal Replacement Therapy Initiation
2025 · Jeff Round, Ilke Akpinar, et al. · JAMA Network Open · 1
PDF
What Can an Ethnography of Orphan Diseases Contribute to an Anthropology of Bio-Pharma?
2010 · Christopher Condin · PsycEXTRA Dataset · 1
SARS-CoV-2 and HCoV IgG Antibodies in the Breast Milk of a Postpartum SARS-CoV-2 Patient Following Bamlanivimab Administration: A Case Report
2025 · Guadalein Tanunliong, Christopher Condin, et al. · COVID
PDF
Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial
2023 · Sean M. Bagshaw, Ary Serpa Neto, et al. · Intensive Care Medicine
PDF
Works count: 8
Citation count: 133
H-index: 4
I10-index: 3
Year
Topic
Type